MainFeedbackSite mapRussian
 

Business Segments

 

News

02.12.2014
«Rigla» - the leader of pharmacy chain rating for 9 months 2014 – rating by IMS
Pharmacy chain Rigla keeps its leadership in a “Complex rating of national pharmacy chains” – rated by IMS, for 9 months 2014. According to the rating, the Rigla’s market share accounted for 3,05%.
29.10.2014
Protek Group announces preliminary operational results for Q3-2014 and 9M-2014
Protek Group (PRTK: RTS, MICEX), a major Russian pharmaceutical company announces its preliminary operational results for Q3-2014 and 9M-2014 according to the management accounts (unaudited)*.
16.09.2014
OAO Protek announces dividend payment based on unaudited 1HY-2014 RAS financial results
OAO Protek (PRTK: RTS, MICEX), a major Russian pharmaceutical company, announces that its General Shareholders Meeting resolved to distribute and pay dividends out of the Company's net profit based on 1HY-2014 RAS financial results.
27.08.2014
Protek Group announces financial results for 1HY-2014
Protek Group (PRTK:RTS, MICEX), one of the major pharmaceutical companies in Russia operating in all the segments of the pharmaceutical market (production, distribution, and retail sales), announces its audited IFRS results for 1HY-2014.
18.07.2014
Pharmaceutical plant “Sotex” opened production site for erythropoietin substance

Pharmaceutical plant “Sotex”, which is part of “PROTEK” group of companies, opened a site for production of genetically engineered erythropoietin substance - active ingredient of drug Eralfon® - as a part of the second stage of developing the plant’s capacity.

24.06.2014
OAO PROTEK held General Shareholders Meeting
On 24 June 24, OAO PROTEK, one of the largest Russian pharmaceutical holding companies, held its annual meeting.
29.04.2014
Protek Group announces preliminary operational results for Q1-2014
Protek Group (PRTK: RTS, MICEX), one of the major pharmaceutical companies in Russia, has announced its preliminary operating results for Q1-2014 according to the management accounts (unaudited).
29.04.2014
Protek Group announces FY-2013 financial results
Protek Group (PRTK:RTS, MICEX), one of the major pharmaceutical companies in Russia operating in all the segments of the pharmaceutical market (production, distribution, and retail sales), has announced its audited IFRS results for FY-2013.
02.04.2014
Changes in personnel of ZAO CV PROTEK

Protek Group is announcing the OAO PROTEK board of management’s decision to accept the dismissal of Igor Filatov, Director General of ZAO CV PROTEK, as he decided to change his professional area and try other business directions. The successor for the Director General position will be Dmitry Pogrebinsky, who used to hold the position of Deputy Director General in logistics and operations.

17.02.2014
«Rigla» - the leader of pharmacy chain’s IMS rating 2013
Pharmacy chain Rigla keeps being the leader in Complex IMS national rating of pharmacy chains for the full year 2013. According to the rating, the Rigla’s market share accounted for 2,90% with 17% up in comparison with corresponding period of last year.
Subscribe
1 2 3 4 5 ... 20



Sotex «PharmFirm» Protek-SVM Protein contour CV Protek Spargo Technologies TRANSSERVICE Customs PROMOPHARM Rigla